炎症性腸疾患の治療の未来:ガイドラインを超えた新しい治療法のレビュー
Mohamed Mahmoud Hafez1, Ibrahim Halil Bahcecioglu2, Mehmet Yalniz2
1Faculty of Medicine, Helwan University, Cairo 11795, Egypt.
World journal of methodology
|September 3, 2025
まとめ
先進的な治療法は 炎症性腸疾患 (IBD) の患者にとって 新しい希望をもたらし,従来の治療法と比較して 治療効果を向上させ,副作用を軽減します. イノベーションには 標的生物学的薬,新薬の投与,より良い胃腸の健康のための微生物の介入が含まれています.
科学分野:
- 胃腸内科
- 免疫学
- 薬理学について
背景:
- クローン病と潰瘍性大腸炎を含む 炎症性腸疾患 (IBD) は慢性疾患である.
- アミノサリチレート,コルチコステロイド,免疫調節剤,生物学的薬などの現在の治療には 高額な費用と副作用などの限界があります.
研究 の 目的:
- IBD治療の最近の進歩をレビューする.
- 新しい治療法や革新的なアプローチを強調する
主な方法:
- 先進的なIBD治療に関する現在の文献のレビュー.
- 新薬クラス,投与システム,介入に関する議論
主要な成果:
- 小分子療法や 標的生物学的薬剤や 微生物群に基づく介入といった 先進的な治療法が 期待を裏切らないようです
- 抗インタールイキン-23阻害剤,S1P受容体調節剤,およびJAK阻害剤などの新興療法では,生物利用性が向上し,副作用が少なく,標的型免疫低下がもたらされます.
- 革新的な薬物投与システム (ナノ粒子,ヒドロゲル) が薬の有効性を改善します.
- 糞便の微生物移植とプロバイオティクスは 腸内微生物のバランスを取り戻すことを目的としています
- AI,高度な内視鏡検査,幹細胞治療は 将来の治療の可能性を表しています
結論:
- 先進的な治療法が単独でも 従来の治療法と併用しても IBDの治療結果が改善されます
- 腸内微生物を再生し 技術の進歩を活用することが 将来の重要な方向です
- IBDの効果的な管理には テクノロジーと遠隔医療を統合した多分野医療が不可欠です
さらに関連する動画
関連する概念動画
Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201


